drugset / Trial / NCT00102752

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

NCT00102752 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety of glufosfamide when administered in combination with gemcitabine.

Timeline

Start
2004-12
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Glufosfamide Small molecule — —
Background Gemcitabine Small molecule — —

Indications